FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s FluMist was approved Friday by regulators for household administration in patients ages 2 to 49. The spray, which has been available via a doctor's visit since 2003, is roughly as as effective as injected vaccines.
The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter ...
Here's what to know about the latest vaccines, who needs them and how they help prevent the more serious effects of COVID-19. The FDA granted emergency use authorization last week to an updated ...
And now, here’s what you might have missed in health and wellness this week. What our team has been interested in: These were ...
LONDON (Reuters) -Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...
You can schedule an appointment at your local pharmacy, such as CVS, Walgreens, Safeway, or your primary care physician to get the RSV vaccine. The CDC said it is safe to get your RSV, flu and COVID ...
ABS-CBN News on MSN6d
DOH: No FDA-registered mpox vaccine yet in PHThe Department of Health (DOH) reiterated that the Food and Drug Administration (FDA) has not approved any mpox vaccine to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback